Sensei Biotherapeutics, Inc. (SNSE)
SNSE Stock Price Chart
Explore Sensei Biotherapeutics, Inc. interactive price chart. Choose custom timeframes to analyze SNSE price movements and trends.
SNSE Company Profile
Discover essential business fundamentals and corporate details for Sensei Biotherapeutics, Inc. (SNSE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Feb 2021
Employees
14.00
Website
https://www.senseibio.comCEO
John K. Celebi
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
SNSE Financial Timeline
Browse a chronological timeline of Sensei Biotherapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$4.11.
Earnings released on 5 Aug 2025
EPS came in at -$3.91 surpassing the estimated -$6.20 by +36.94%.
Stock split effective on 17 Jun 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 6 May 2025
EPS came in at -$5.40 falling short of the estimated -$4.20 by -28.57%.
Earnings released on 28 Mar 2025
EPS came in at -$5.40 matching the estimated -$5.40.
Earnings released on 14 Nov 2024
EPS came in at -$0.29 surpassing the estimated -$0.31 by +6.45%.
Earnings released on 6 Aug 2024
EPS came in at -$0.28 falling short of the estimated -$0.25 by -12.00%.
Earnings released on 9 May 2024
EPS came in at -$0.32 falling short of the estimated -$0.29 by -10.34%.
Earnings released on 28 Feb 2024
EPS came in at -$0.30 surpassing the estimated -$0.32 by +6.25%, while revenue for the quarter reached $2.85M .
Earnings released on 7 Nov 2023
EPS came in at -$0.28 matching the estimated -$0.28.
Earnings released on 3 Aug 2023
EPS came in at -$0.31 surpassing the estimated -$0.32 by +3.13%.
Earnings released on 9 May 2023
EPS came in at -$0.33 surpassing the estimated -$0.35 by +5.71%.
Earnings released on 28 Mar 2023
EPS came in at -$0.40 surpassing the estimated -$0.41 by +2.44%.
Earnings released on 8 Nov 2022
EPS came in at -$0.44 falling short of the estimated -$0.37 by -18.92%.
Earnings released on 9 Aug 2022
EPS came in at -$0.34 surpassing the estimated -$0.40 by +15.00%.
Earnings released on 10 May 2022
EPS came in at -$0.40 falling short of the estimated -$0.35 by -14.29%.
Earnings released on 10 Mar 2022
EPS came in at -$0.29 surpassing the estimated -$0.34 by +14.71%.
Earnings released on 9 Nov 2021
EPS came in at -$0.32 falling short of the estimated -$0.25 by -28.00%.
Earnings released on 4 Aug 2021
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%.
Earnings released on 12 May 2021
EPS came in at -$0.42 falling short of the estimated -$0.33 by -27.27%.
Earnings released on 25 Mar 2021
EPS came in at -$2.71 surpassing the estimated -$2.96 by +8.45%.
Earnings released on 4 Feb 2021
EPS came in at -$0.44 .
SNSE Stock Performance
Access detailed SNSE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.